Oligomers Role in Seeding and Nucleating Amyloid Fibrils

About the Research Project
Program
Award Type
Standard
Award Amount
$100,000
Active Dates
April 01, 2005 - January 31, 2009
Grant ID
A2005315
Co-Principal Investigator(s)
Summary
Aβ is one of many peptides and proteins associated with AD. Yet, while the peptides and proteins associated with these diseases are unique in sequence, recent evidence suggests that they share common pathways for aggregation, common structural features at each stage of aggregation, and perhaps common mechanisms of toxicity. The aggregation pathway contains intermediate conformations referred to as soluble spherical oligomers. Dr. Kayed will test hypotheses regarding the role of soluble oligomers in fibril formation. The long term goal of this project is to better understand the mechanisms of the process of amyloid fibril formation in order to effectively interrupt and/or hinder amyloid formation in AD and perhaps other degenerative diseases.
Grants
Related Grants
Alzheimer's Disease Research
Regulatory Mechanisms Underlying Endosomal Targeting of SORL1
Active Dates
January 01, 2025 - December 31, 2026
Principal Investigator
Olav Andersen, PhD
Regulatory Mechanisms Underlying Endosomal Targeting of SORL1
Active Dates
January 01, 2025 - December 31, 2026

Principal Investigator
Olav Andersen, PhD
Alzheimer's Disease Research
The Role of DYRK1A in Altered Microglia Biology in a Cellular Model of Alzheimer’s Disease in Down Syndrome
Active Dates
January 01, 2025 - December 31, 2027
Principal Investigator
Frances Wiseman, PhD
The Role of DYRK1A in Altered Microglia Biology in a Cellular Model of Alzheimer’s Disease in Down Syndrome
Active Dates
January 01, 2025 - December 31, 2027

Principal Investigator
Frances Wiseman, PhD
Alzheimer's Disease Research
Synergistic Effects of Biological Sex and Sleep Loss in an AD Mouse Model
Active Dates
January 01, 2025 - December 31, 2026
Principal Investigator
Mallar Chakravarty, PhD
Synergistic Effects of Biological Sex and Sleep Loss in an AD Mouse Model
Active Dates
January 01, 2025 - December 31, 2026
Principal Investigator
Mallar Chakravarty, PhD